We are live on
!
Find out more
RCM
Radnor Capital Management Portfolio holdings
AUM
$712M
1-Year Est. Return
34.39%
This Fund
S&P 500
This Quarter
Est. Return
-5.7%
1 Year Est. Return
+34.39%
3 Year Est. Return
+86.61%
5 Year Est. Return
+116%
10 Year Est. Return
–
AUM
$345M
AUM Growth
-$20.8M
(-5.7%)
Cap. Flow
+$4.39M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
33.39%
Holding
238
New
5
Increased
70
Reduced
56
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.62M |
| 2 |
IBM
IBM
|
+$1.52M |
| 3 |
Comcast
CMCSA
|
+$1.27M |
| 4 |
3M
MMM
|
+$1.05M |
| 5 |
Ross Stores
ROST
|
+$269K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$917K |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$414K |
| 3 |
Deutsche Bank
DB
|
+$274K |
| 4 |
Halliburton
HAL
|
+$261K |
| 5 |
Ametek
AME
|
+$257K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.19% |
| 2 | Technology | 14.21% |
| 3 | Industrials | 12.47% |
| 4 | Energy | 11.79% |
| 5 | Financials | 9.67% |
Similar funds
PCS
AMPWP
DCM
TLP
DCM
IWP
LS
SSP
Radnor Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Radnor Capital Management held 238 positions worth $345M, down 5.7% from $366M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Radnor Capital Management's Q3 2022 filing shows 5 new, 70 increased, 56 reduced and 9 closed positions. Its largest new stake was Ross Stores: 3,165 shares worth $267K. The largest sale was Atlas Air Worldwide Holdings, Inc., an estimated $917K.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.
- Radnor Capital Management's largest Q3 2022 buy was Ross Stores: 3,165 shares worth $267K.
- Radnor Capital Management added most to ExxonMobil in Q3 2022, an estimated $1.62M increase.
- Radnor Capital Management's biggest Q3 2022 reduction was Atlas Air Worldwide Holdings, Inc., cutting an estimated $917K.
- Radnor Capital Management fully exited Regeneron Pharmaceuticals in Q3 2022, selling an estimated $414K.
- Radnor Capital Management's ten largest holdings make up 33% of its $345M portfolio in Q3 2022.
- Radnor Capital Management opened 5 new positions and closed 9 in Q3 2022.
- Radnor Capital Management's portfolio value fell 5.7% quarter-over-quarter to $345M.
Based on Radnor Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.